Cerebrospinal fluid proteomics for identification of potential biomarkers to monitor pharmacological therapeutic efficacy in dopamine dictated disease states of Parkinson's disease and schizophrenia
2019 ◽
Vol Volume 15
◽
pp. 2853-2867
◽
Keyword(s):
Keyword(s):
2016 ◽
Vol 54
(10)
◽
pp. 7736-7745
◽
Keyword(s):
2021 ◽
Vol 34
(4)
◽
pp. 253-262
1996 ◽
Vol 211
(1)
◽
pp. 13-16
◽